Pharma channel feed – Endpoints News

Pharma channel feed

Following its latest setback, Achillion posts some encouraging PoC data for lead drug

6 years ago

Takeda, Frazier create Phathom Pharmaceuticals to spur development of GI drug vonoprazan in $140M play

6 years ago

Four years after EU approval, NICE finally backs Revlimid use in certain first-line multiple myeloma patients

6 years ago

After a long march with Cabo, Exelixis is expanding its focus with an antibody-drug conjugate deal

6 years ago

Analysts spotlight the winners — and losers — on ASCO preview night

6 years ago

J&J polishes up its new list of late-stage blockbuster candidates — and cancer remains big

6 years ago

ImmunoGen shares tank (again) after the FDA nixes a shot at an OK for its armed antibody in wake of a failed PhIII

6 years ago

Pfizer, Merck KGaA clinch needed approval for Bavencio, directly competing against Keytruda in kidney cancer

6 years ago

Almost half of all new drug approvals in 2018 relied on one clinical trial

6 years ago

Boehringer Ingelheim flies the white flag as last holdout surrenders in war over a $20B AbbVie gold mine

6 years ago

Biopharma BD teams are speeding into the fast lane — cash in hand — as dealmaking continues to heat up in Q1 offensive

6 years ago

Daiichi Sankyo faces FDA challenges on missing data, credibility and safety concerns in hunt for 2 new drug OKs

7 years ago

‘Too big to care’: Sweeping lawsuit accuses Teva of colluding with other generic makers to keep prices high

7 years ago

Engulfed in legal trouble, bankruptcy could be the answer for opioid drugmaker Insys

7 years ago

Puma investors fret, as Nerlynx Q1 sales fall uncomfortably short of Wall Street estimates

7 years ago

ICER chastises J&J for overpricing depression drug esketamine ‘where there is such need for treatment’

7 years ago

Takeda inks a pair of sales to Novartis and J&J for up to $5.7B, handing over 485 staffers

7 years ago

List prices in drug ads on TV coming as CMS finalizes rule

7 years ago

Work with Florida on its drug import program, Trump tells Azar — report

7 years ago

Tillman Gerngross isn't out to impress you with biobucks, but here are 3 partner deals that should

7 years ago

Pfizer buys a rare disease biotech for $340M-plus, putting them on a path to compete with BioMarin

7 years ago

Rattle and hum: Roche, PTC post update on their SMA drug as a shaken Biogen faces yet another franchise buster

7 years ago

Allergan chief Saunders takes a painful $2.5B hit on an ugly PhIII flop

7 years ago

Catching Catalyst Pharma by surprise, FDA approves Jacobus LEMS drug for pediatric patients — based on adult data

7 years ago

First page Previous page 269 270 271272273 274 275 Next page Last page